Skip to main content
. Author manuscript; available in PMC: 2011 Jun 6.
Published in final edited form as: Int J Dev Neurosci. 2004 Aug-Oct;22(5-6):321–328. doi: 10.1016/j.ijdevneu.2004.03.002

Table 1.

Receptor number, Bmax (fmol 125I OTA/mg protein) from oxytocin receptor saturation binding

Brain area Treatment
F
Saline Cocaine Fluoxetine Amfonelic acid/fluoxetine
Amygdala 6.73 ± 0.20 7.89 ± 0.27* 7.91 ± 0.13* 6.31 ± 0.35 10.51
MPOA 13.28 ± 0.84 8.68 ± 0.52† 9.72 ± 1.12 12.18 ± 0.90 5.96
Hippocampus 9.55 ± 0.73 5.99 ± 0.60 6.07 ± 1.04 8.06 ± 2.40 1.49
VTA 4.60 ± 0.31 3.75 ± 0.39 3.13 ± 0.43 4.42 ± 0.37 3.18

Results are mean ± S.E.M. of three determinations for each treatment group.

*

P < 0.05 vs. saline and amfonelic acid/fluoxetine.

†

P < 0.05 vs. saline.